Abstract:The devastating impact of Coronavirus Disease 2019 (COVID-19) on human health globally has prompted extensive discussions on how to better prepare for and safeguard against the next pandemic. Zoonotic spillover of pathogens from animals to humans is recognized as the predominant cause of emerging infectious diseases and as the primary cause of recent pandemics [1]. This spillover risk is increased by a range of factors (called drivers) that impact the nature, frequency, and intensity of contact between humans and wild animals. Many of these drivers are related to human impact, for example, deforestation and changes in land use and agricultural practices. While it is clear that the triad of prevention-preparedness-response (P-P-R) is highly relevant, there is much discussion on which of these 3 strategic activities in the field of emerging infectious disease should be prioritized and how to optimally target resources. For this, it is important to understand the scope of the respective activity and the consequences of prioritization. Already, the World Bank Pandemic Fund and forthcoming global Pandemic instrument [2] negotiated by the World Health Organization (WHO) [3] appear primarily focused on the early detection, and reaction to the appearance of human illnesses, often with explicit focus only on action to be taken once pathogen spillover and spread have occurred. Strategies to reduce the probability of spillover events are under-prioritized and underutilized, as highlighted by recent infectious disease crises such as Ebola and Mpox epidemics, and have been lost in overall preparedness discussions and recovery financing. This "more of the same" focus suggests that it is politically more expedient to allocate financial resources to deal with a problem once it has arisen, rather than taking the steps necessary to reduce the risk of it occurring in the first place. It is often claimed that allocating resources to prevent something from happening is politically difficult as the value of prevention is largely "invisible" (prevention paradox) or it will take a long time to show effects. However, there are now several communications highlighting the economic benefits of prevention of spillover [1,4,5]. If taken, actions to prevent spillover are estimated at 4 billion per year in social benefits from reduced greenhouse gas emissions [4]. COVID-19 has demonstrated the immense burden of a pandemic, including significant mortality resulting in economic recession, with the global economy contracting by 4.4 percent in 2020. The expected economic losses from this pandemic are estimated at nearly 52 billion; the Ebola virus disease outbreak in West Africa in 2014 to 2016 with a GDP loss of 53.19 billion [8]; and the 2015 to 2016 Zika virus disease outbreak with an estimated loss in the United States, Caribbean, and Latin America of $20 billion [9,10]. If invested in, prevention strategies would reduce the likelihood of another pandemic substantially and likely generate sufficient return on investment over time while also having the potential to generate substantial co-benefits [1,10]. Prevention is already valued in other sectors: policymakers and industries have led on prevention in other areas, such as expenditure on counter-terrorism, driving laws and insurance incentives to reduce the frequency of traffic accidents, on the nuclear deterrent, and in some cases on flood prevention and other water management measures, exemplifying a political willingness to spend vast sums of money to preempt a harmful event in certain areas or circumstances, but not on pandemic prevention.

Focusing Viral Risk Ranking Tool on Prediction

Prediction of viral spillover risk based on the mass action principle

Ranking the risk of animal-to-human spillover for newly discovered viruses

Hidden Challenges in Evaluating Spillover Risk of Zoonotic Viruses using Machine Learning Models

Identifying and prioritizing potential human-infecting viruses from their genome sequences

Bridging the gap: Using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa

Spillover rate is not predictive of host jump risk

Predicting potential SARS-CoV-2 spillover and spillback in animals

What is the relationship between viral prospecting in animals and medical countermeasure development?

Host and viral traits predict zoonotic spillover from mammals

A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia

Reservoir host immunology and life history shape virulence evolution in zoonotic viruses

Pandemic-Proofing: Intercepting Zoonotic Spillover Events

Features that matter: evolutionary signatures that predict viral transmission routes

Prevention of zoonotic spillover: From relying on response to reducing the risk at source

Features that matter: Evolutionary signatures can predict viral transmission routes

Using serosurveys to optimize surveillance for zoonotic pathogens

Pathogen spillover driven by rapid changes in bat ecology

Epidemiological inference at the threshold of data availability: an influenza A(H1N2)v spillover event in the United Kingdom

A protocol and a data-based prediction to investigate virus spillover at the wildlife interface in human-dominated and protected habitats in Thailand: The Spillover Interface project